Barclays PLC is an international financial services provider engaged in personal, corporate and investment banking, credit cards and wealth management with an extensive presence in Europe, the Americas, Africa and Asia. The company was founded in 1896 and is based in London, United Kingdom.
A new investment of $20 million takes the total capital raised by behavioral biometrics innovator BioCatch to more than $213 million. Participating in this week’s funding were a quartet of major global banks: Barclays, Citi, HSBC, and National Australia Bank (NAB). The funds add to BioCatch’s Series C round, which brought $145 million to the Read more… The post BioCatch Secures $20 Million to Drive Innovation in Behavioral Biometrics appeared first on Finovate .
FTSE Russell’s Chinese government bond move heralds fresh opportunities for hedge fund investors Submitted By Hugh Leask | 01/10/2020 - 5:15pm FTSE Russell’s decision to include Chinese sovereign bonds in its flagship government bond index could offer hedge fund investors fresh alpha-generating and AUM-raising opportunities amid a wave of overseas capital inflows into the market. FTSE Russell said last month it intends to include Chinese sovereign bonds into its flagship World Government Bond Index from next year. The inclusion – which follows similar moves by Bloomberg Barclays and JP Morgan Chase, the other two main index compilers – tees up a range of investment opportunities for several hedge fund strategy types, industry observers said. Man Group, the London-listed global hedge fun...
Israeli behavioral biometrics company BioCatch announced that four major global banks – Barclays, Citi, HSBC and National Australia Bank (NAB) – have invested $20 million in the company, expanding the company’s recent Series C financing round to $168 million raised. Read more here. The post [BioCatch in Globes] Major banks invest $20m in biometrics co BioCatch appeared first on OurCrowd Blog .
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--BioCatch, the global leader in behavioral biometrics, today announced that four major global banks – Barclays, Citi, HSBC and National Australia Bank (NAB) – have invested $20 million in the company, extending the company’s recent Series C fundraising round to a total of $168 million raised. In conjunction with the funding, BioCatch has established the BioCatch Client Innovation Board. The invitation-only Innovation Board will be a collaborative for